Skip to main content
logo
Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
20.07
+0.34 (1.72%)
At close: Jan 30, 2026, 4:00 PM EST
20.35
+0.28 (1.39%)
After-hours: Jan 30, 2026, 7:56 PM EST

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2021FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
6.08B5.85B
Emerging Markets Revenue
1.35B1.35B
Rest of World Revenue
3.60B3.44B
Revenue (Total)
11.02B10.64B

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2021FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Infusion Therapies Revenue
4.06B4.10B
Advanced Surgery Revenue
1.16B1.10B
Medical Products & Therapies Revenue
5.23B5.21B
Care & Connectivity Solutions Revenue
1.88B1.81B
Front Line Care Revenue
1.15B1.14B
Healthcare Systems & Technologies Revenue
3.03B2.95B
Injectables and Anesthesia Revenue
1.38B1.37B
Drug Compounding Revenue
1.09B1.04B
Pharmaceuticals Revenue
2.47B2.41B
Other Revenue (Post-Q2 2023 Reporting)
302.00M67.00M
Revenue (Total)
11.02B10.64B

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2021FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Medical Products & Therapies Operating Income
973.00M950.00M
Healthcare Systems & Technologies Operating Income
460.00M468.00M
Pharmaceuticals Operating Income
285.00M313.00M
Other Operating Income
23.00M18.00M
Operating Income (Total)
411.00M14.00M
Updated Oct 30, 2025. Data Source: Fiscal.ai.